(2S*,5S*)-1-benzyl 2-ethyl 5-hydroxypiperidine-1,2-dicarboxylate, 97%, 50mg

2,5-Dichloro-1,3,4-thiadiazole, 98%, 250mg

3-Ethoxyphenyl boronic acid, 98.0%, 5g

2-Chloro-1H-benzimidazole, 97.0%, 10g

5,6-Dichloropyridazin-3(2H)-one, 95.0%, 25g

2'-Methylformanilide>98.0%(GC)5g

2,7-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9,9'-spirobi[fluorene], 98% HPLC,T, 5g

2-methyl-4-(4-methylpiperazin-1-yl)-6-(piperazin-1-yl)pyrimidine, 95.0%, 250mg

6-(tert-Butyl)nicotinic acid, 95.0%, 25g

ARCA Cap Analog, ≥98%, 50 µl, plastic package.

1-Chloro-5-fluoro-2-[(4-fluorobenzyl)oxy]-4-nitrobenzene, 25mg

N-Hydroxy-acetimidic acid ethyl ester, 97.0%, 25g

1-(5-Amino-2-hydroxyphenyl)ethanone, 95.0%, 5g